EUVIMEDEUVIMED entdecken
Leserbrief

Comment on “Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity”

Alok Kumar Dash iD, Suraj Mandal

Neurourology and Urodynamics · 12.11.2026

DOI: 10.1002/nau.70511 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Neurourology and Urodynamics, online erschienen am 12.11.2026. Verfasst von Alok Kumar Dash und 1 weiteren Autor:innen. Beteiligte Einrichtung: Professor, Madan Mohan Malviya University of Technology, Gorakhpur, Uttar Pradesh, India. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

competing risks analysiscomposite endpointslong‐term effectivenessneurogenic detrusor overactivityonabotulinumtoxin Arenal functionspinal cord injurytreatment adherencetreatment discontinuationurodynamic outcomes

Autor:innen und Institutionen

  • Professor, Madan Mohan Malviya University of Technology, Gorakhpur, Uttar Pradesh, India.
  • Sujata Research Laboratories, Global Sujata Ventures LLP, Vill- Mataiyalalpur, Post-Ramnagra, Tah-Kalinagar, Dist-Pilibhit, Uttar Pradesh, India.

ORCID-Profile: Alok Kumar Dash

Zitieren

APA

Dash, A. K., & Mandal, S. (2026). Comment on “Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity”. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70511

Vancouver

Dash AK, Mandal S. Comment on “Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity”. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70511

BibTeX
@article{Dash2026,
  author = {Dash, Alok Kumar and Mandal, Suraj},
  title = {Comment on “Long‐Term Clinical Effectiveness of and Adherence to Onabotulinumtoxin A Injections for Neurogenic Detrusor Overactivity”},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70511}
}
Kostenlos starten →